論文

査読有り 国際誌
2018年8月

Predictive power of home blood pressure indices at baseline and during follow-up in hypertensive patients: HOMED-BP study.

Hypertension research : official journal of the Japanese Society of Hypertension
  • Daisuke Watabe
  • Kei Asayama
  • Tomohiro Hanazawa
  • Miki Hosaka
  • Michihiro Satoh
  • Daisaku Yasui
  • Taku Obara
  • Ryusuke Inoue
  • Hirohito Metoki
  • Masahiro Kikuya
  • Yutaka Imai
  • Takayoshi Ohkubo
  • 全て表示

41
8
開始ページ
622
終了ページ
628
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1038/s41440-018-0050-4

We compared the predictive power for a major adverse cardiovascular event (MACE) of four home blood pressure (BP) indices (systolic BP, diastolic BP, mean BP, and pulse pressure (PP)) obtained at baseline before treatment and during the on-treatment follow-up period in 3147 patients with essential hypertension (women: 50.1%, mean age: 59.5 years). Associations between MACE and each index were determined using Cox proportional hazard models and the likelihood ratio (LR) test. During a median follow-up of 5.4 years, 46 patients experienced MACE, which was a composite of cardiovascular death, non-fatal stroke, and non-fatal myocardial infarction. The LR test showed that systolic, diastolic, and mean BP during follow-up was more closely associated with cardiovascular risk than the corresponding indices at baseline (LR χ2 for baseline versus follow-up: systolic BP, (6.0, P = 0.014) versus (11.3, P = 0.0008); diastolic BP, (0.4, P = 0.53) versus (12.4, P = 0.0004); mean BP, (3.2, P = 0.074) versus (15.0, P = 0.0001)), whereas neither PP at baseline nor that during follow-up was significantly associated with MACE risk. Among home BP indices during follow-up, mean BP further improved prediction models in which systolic or diastolic BP was already included (P ≤ 0.042), but neither systolic nor diastolic BP improved models with mean BP (P = 0.80). In addition to home systolic and diastolic BP, mean BP during follow-up period provides essential information in predicting future cardiovascular diseases, whereas its utilization should be further assessed by an intervention trial targeting mean BP levels.

リンク情報
DOI
https://doi.org/10.1038/s41440-018-0050-4
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29808033
ID情報
  • DOI : 10.1038/s41440-018-0050-4
  • ISSN : 0916-9636
  • PubMed ID : 29808033

エクスポート
BibTeX RIS